Your browser doesn't support javascript.
loading
Pharmacogenetic role of XRCC1 polymorphisms on the clinical outcome of gastric cancer patients with platinum-based chemotherapy: a systematic review and meta-analysis.
Xu, J; Ma, J; Zong, H T; Wang, S Y; Zhou, J W.
Afiliação
  • Xu J; Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Ma J; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zong HT; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang SY; Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China sywang@njmu.edu.cn.
  • Zhou JW; Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China.
Genet Mol Res ; 13(1): 1438-46, 2014 Mar 06.
Article em En | MEDLINE | ID: mdl-24634242

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Platina / Polimorfismo Genético / Neoplasias Gástricas / Proteínas de Ligação a DNA / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Platina / Polimorfismo Genético / Neoplasias Gástricas / Proteínas de Ligação a DNA / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article